Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Crown Bioscience announced the appointment of Laurie Heilmann as President of CrownBio Global Life Science Product and Diagnostic Solutions.
read more
Paragon Bioservices has appointed Gerard Fleury as Chief Financial Officer.
read more
Dalton Pharma Services has successfully received a ‘Compliant’ rating from the Health Products and Food Branch Inspectorate of Health Canada.
read more
Microbiotica has entered into a multi-year strategic collaboration with Genentech to discover, develop and commercialize biomarkers, targets and medicines for inflammatory bowel disease.
read more
Pharmaceutical Product Development, LLC (PPD), a global contract research organization (CRO), and NeoGenomics Laboratories, Inc., a provider of cancer-focused genetic testing services, are forming a strategic alliance to provide a seamless and fully ...
read more
International Business Development. Hill brings strong operational insight into the nuances and challenges of a wide range of clinical studies – from cutting-edge early phase gene therapy to real-world evidence and patient registries – along with ...
read more
Bracket has announced that James Jay has joined the Company as Senior Vice President, Endpoint Solutions, reporting to Bracket’s Chief Executive Officer, Mike Nolte. In this role, James will lead the Bracket business focused on eCOA, Rater Training, ...
read more
Alcami has reached an agreement to be acquired by Madison Dearborn Partners (MDP).
read more
Ajinomoto Althea announced that Bert Barbosa and Darwin Richardson, MBA, have joined Althea as Vice President of Drug Product Manufacturing and Vice President of Compliance, respectively.
read more
Syndax and Nektar announced a non-exclusive, clinical collaboration to evaluate the safety and efficacy of NKTR-214 in combination with entinostat in patients with metastatic melanoma who have previously progressed on treatment with an anti-PD-1 ...
read more
Cambrex announced it will start a $5 million expansion of laboratory facilities at its Karlskoga, Sweden site.
read more
Amneal has received FDA approval on its ANDA for Cyclophosphamide for Injection USP, the company's AP-rated therapeutic equivalent to Cytoxan 500 mg, 1 g and 2 g Single-Dose Vials.
read more
Cloud Pharmaceuticals have entered into drug discovery collaboration with GlaxoSmithKline.
read more
Teikoku Pharma USA has entered into an exclusive license agreement with Link Health Group to develop market, sell, and distribute Lidoderm in China.
read more
MabPlex has established their new state of the art Process Development Center of Excellence located in La Jolla, CA with scale up capacity to 200L.
read more